Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: A pilot study

Table 7 Impact of ANA and SMA alterations at the three time-points of investigation on the sustained virological response of the patients.

	Virological response at the end of follow up [n (%)]
	n	Yes	No	P
Alteration of ANA titres
Increase	20	8 (40)	12 (60)	0.02
Decrease	13	8 (61.5)	5 (38.5)
Constant	24	4 (16.7)	20 (83.3)
Alteration of SMA titres
Increase	14	3 (21.4)	11 (78.6)	0.003
Decrease	18	12 (66.7)	6 (33.3)
Constant	25	5 (20)	20 (80)

Abbreviations are same as in the text. n = the number of individuals in each group of patients. Alterations of autoantibodies titres are referred to the period from entry to end of follow-up. P values were calculated by total χ².